CINECA IRIS Institutional Research Information System

BONINO, FERRUCCIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.751
AS - Asia 11.312
EU - Europa 7.231
SA - Sud America 1.528
AF - Africa 178
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 43.017
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.039
CN - Cina 3.834
SG - Singapore 3.289
IT - Italia 2.043
HK - Hong Kong 2.024
BR - Brasile 1.325
SE - Svezia 1.188
BG - Bulgaria 895
KR - Corea 759
UA - Ucraina 668
CA - Canada 620
VN - Vietnam 579
DE - Germania 558
RU - Federazione Russa 378
GB - Regno Unito 373
FI - Finlandia 350
TR - Turchia 345
FR - Francia 294
CH - Svizzera 262
IN - India 131
AR - Argentina 86
BD - Bangladesh 71
JP - Giappone 52
AT - Austria 49
MX - Messico 44
ZA - Sudafrica 37
ID - Indonesia 36
BE - Belgio 33
EC - Ecuador 33
CI - Costa d'Avorio 31
IQ - Iraq 30
SA - Arabia Saudita 25
EG - Egitto 24
NL - Olanda 21
PK - Pakistan 21
UZ - Uzbekistan 20
MA - Marocco 19
CO - Colombia 18
CZ - Repubblica Ceca 16
ES - Italia 15
KE - Kenya 15
BJ - Benin 14
PY - Paraguay 14
VE - Venezuela 14
CL - Cile 13
IE - Irlanda 13
PL - Polonia 13
RO - Romania 13
AE - Emirati Arabi Uniti 12
NP - Nepal 12
HU - Ungheria 11
PE - Perù 11
TT - Trinidad e Tobago 9
IR - Iran 8
PH - Filippine 8
SN - Senegal 8
UY - Uruguay 8
CR - Costa Rica 7
DZ - Algeria 7
AL - Albania 6
GR - Grecia 6
RS - Serbia 6
TN - Tunisia 6
AU - Australia 5
DO - Repubblica Dominicana 5
HN - Honduras 5
JM - Giamaica 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
TH - Thailandia 5
TW - Taiwan 5
BO - Bolivia 4
ET - Etiopia 4
MY - Malesia 4
NG - Nigeria 4
OM - Oman 4
XK - ???statistics.table.value.countryCode.XK??? 4
AZ - Azerbaigian 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
PA - Panama 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BN - Brunei Darussalam 2
BZ - Belize 2
CY - Cipro 2
DK - Danimarca 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
KW - Kuwait 2
LB - Libano 2
LT - Lituania 2
LV - Lettonia 2
Totale 42.985
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.810
Fairfield 2.353
Ashburn 2.216
Hong Kong 2.012
Ann Arbor 1.828
Singapore 1.719
Houston 1.716
Chandler 1.089
Hefei 1.036
Milan 990
Seattle 951
Sofia 895
Jacksonville 878
Dallas 854
Wilmington 774
Seoul 757
Cambridge 726
Santa Clara 688
Shanghai 650
Beijing 603
New York 574
Ottawa 551
Boardman 378
Princeton 359
Lawrence 354
Medford 317
Des Moines 303
Nanjing 269
Bern 253
Los Angeles 219
Buffalo 169
Dearborn 169
Istanbul 160
Izmir 158
Jüchen 155
Frankfurt am Main 144
Dong Ket 136
Nanchang 121
San Diego 119
Redondo Beach 108
Ho Chi Minh City 103
São Paulo 96
Kunming 84
Changsha 65
Shenyang 63
Rome 61
Council Bluffs 57
Hebei 57
Ogden 53
Munich 48
Redwood City 48
Tianjin 42
Boulder 40
Rio de Janeiro 40
Vienna 40
Pisa 39
Belo Horizonte 38
Hanoi 37
Jiaxing 37
Chicago 36
Pune 36
London 35
Lancaster 34
Tokyo 33
Turku 33
Abidjan 31
Brussels 31
Norwalk 31
The Dalles 31
Columbus 29
Florence 29
San Jose 29
Washington 28
Brasília 26
Jinan 26
Guangzhou 23
Falls Church 22
Hangzhou 21
Paris 21
Curitiba 20
Fuzhou 20
Tashkent 19
Toronto 19
Verona 19
Nuremberg 18
Orange 18
San Francisco 18
Dhaka 17
Phoenix 17
Campinas 16
Serra 15
Auburn Hills 14
Cotonou 14
Goiânia 14
Salvador 14
Cairo 13
Montreal 13
Chennai 12
Fortaleza 12
Nairobi 12
Totale 32.528
Salva come PNG Salva come JPEG
Nome #
Active HBV replication in HBsAg carriers with chronic Delta infection 238
Animal model for liver cell banking from non-heart beating donors after prolongedischaemia time 234
A histological study of hepatitis delta virus liver disease 223
Delta hepatitis in inapparent carriers of hepatitis B surface antigen 216
Serum markers of hepatitis B virus replication, liver histology and intrahepatic expression of hepatitis B core antigen 213
Prognostic significance of in-vitro complement fixation in liver biopsy specimens from patients with acute viral hepatitis type B 209
Chronic Hepatitis in Carriers of Hepatitis B Surface Antigen, with Intrahepatic Expression of the Delta Antigen 209
Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen 208
Diagnosis of Budd-Chiari syndrome by pulsed Doppler ultrasound 208
Normal lymphocyte interferon production in adult HBsAg-positive chronic active liver disease 207
Hepatitis B virus replication and clinical outcome in carriers of HBsAg.Perspectives of treatment with DNA inhibitors 207
Levamisole and chronic delta hepatitis 202
Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBe 202
The importance of hepatitis B viral DNA in serum and liver 195
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment 195
Sequence variation in hepatitis C viral isolates 194
Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D 193
A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B 192
Delta hepatitis agent: structural and antigenic properties of the delta-associated particle 191
Experimental transmission of the delta agent to chimpanzees 190
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis 190
A precore-defective mutant of hepatitis B virus associated with e antigen-negative chronic liver disease 188
Familiar clustering and spreading of hepatitis delta virus infection 186
REPLICATING AND VIRION SECRETING HEPATITIS B MUTANT VIRUS UNABLE TO PRODUCE PRES2 PROTEIN 183
Complexes between HBsAg and IgM in serum of patients with acute hepatitis 181
Hepatitis delta virus, a model of liver cell pathology 181
Superimposed Hepatitis and the Effect on Viral replication in Chronic Hepatitis B 180
Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: a specific liver disease? 180
Role of IgM antibody to hepatitis B core antigen in the diagnosis of hepatitis B exacerbations 179
T-lymphocyte response to hepatitis C virus in different clinical courses of infection 179
The natural history of chronic delta hepatitis 178
Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated with hepatitis B virus in liver and in serum of HBsAg carriers 178
Trasmission of the hepatitis B virus-associated delta agent to the eastern woodchuck 176
Expression of estrogen receptor mRNA in tumorous and non-tumorous liver tissue as detected by in situ hybridization 176
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases 176
High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders 174
Effects of a bicarbonate-alkaline mineral water on gastric functions and functional dyspepsia: a preclinical and clinical study 174
Precore mutant hepatitis B virus and outcome of chronic infection and hepatitis in hepatitis B e antigen-positive children 173
AN ESSAY FOR CIRCULATING ANTIBODIES TO A MAJOR ETIOLOGIC VIRUS OF HUMAN NON-A, NON-B HEPATITIS 172
Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology 171
Quantitative analysis of IgM anti-HBc in chronic hepatitis B patients using a new "gray-zone" for the evaluation of "borderline" values 171
Variants of hepatitis B virus 170
Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects 170
Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview 170
A multiphase model of th dynamics of HBV infection in HBeAg-negative patients during pegylated interferon-alfa2a, lamivudine and combination therapy 170
The e antigen and antibody in the serum of patients with HBsAg-positive liver disease and in asymptomatic carriers 169
Antibodies against the human pancreas in acute and chronic liver disease 169
Severe liver injury possibly due to verapamil 169
Hepatitis B virus heterogeneity, one of many factors influencing the severity of hepatitis B 169
Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study 168
Delta agent (type D) hepatitis 168
Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein 167
Liver stiffness, a non-invasive marker of liver disease in the HBV carrier 167
Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers 167
Properties of delta-associated ribonucleic acid 166
Hepatitis B virus unable to secrete e antigen 166
Hepatitis C virus infection in type II essential mixed cryoglobulinemias 166
Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography. 165
Steato-Score: Non-Invasive Quantitative Assessment of Liver Fat by Ultrasound Imaging 165
Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin 164
Software and expert system for the management of chronic hepatitis B 164
Multicenter evaluation of the elecsys hepatitis B surface antigen quantitative assay 164
Detection of HBV-DNA by in-situ hybridization using a biotin- labeled probe 163
Characterization of hepatitis delta antigen gene of a highly pathogenic strain of hepatitis delta virus 163
Possible immunopathogenesis for fibrosing cholestatic hepatitis 163
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B 163
Chronic Delta Hepatitis 162
Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C 161
Problems in diagnosing viral hepatitis 159
Reduced expression of the melanocortin-1 receptor in human liver during brain death 159
Quantitative analysis of wild-type and HBeAg minus hepatitis B viruses by a sequence-dependent primer extension assay 158
Impact of interferon-alpha therapy on the development of hepatocellular carcinoma in patients with liver cirrhosis: results of an international survey 158
A dynamic analysis of IgM anti-HCV helps to distinguish hepatitis C from acute rejection in liver transplant patients 158
Introduction to 'Hepatitis B virus heterogeneity--a means to personalized care' 158
Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research 158
IgM antibody against measles virus in patients with inflammatory bowel disease: a marker of virus-related disease? 157
Treatment of chronic hepatitis B: from research to clinical practice via the consensus conferences 157
New immunoassays for total, IgA and IgM antibodies against hepatitis E virus: Prevalence in Italian blood donors and patients with chronic liver or kidney diseases 157
Validation and comparison of different PCR-based methods for detection of Hepatitis B virus precore region mutants 156
Hepatitis B virus surface antigen levels: a guide to sustained response to Peginterferon alfa-2a in HBeAg-negative chronic hepatitis B 156
Viral load 1 week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis C 156
Incidence and significance of different types of connective tissue antibodies in adult and pediatric gastroenterological disorders 155
Early and accurate prediction of Peg-IFNs/ribavirin therapy outcome in the individual patient with chronic hepatitis C by modeling the dynamics of the infected cells 155
Mitochondrial antibody in Italy: diagnostic value in primary biliary cirrhosis 154
Patterns of natural killer cell function activation in response to interferon in chronic HBsAG positive hepatitis: relationship with the state of viral infection and with the early clinical response 154
Uridine diphosphate glucoronosyl transferases, candidate antigens of liver-kidney microsomal antibodies in hepatitis delta virus-infected patients 154
Comparable function of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors 154
Role of hepatitis delta virus infection in hepatocellular carcinoma 153
Personalized Therapy in chronic viral hepatitis 152
Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares 152
Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection. 152
Rapidly progressive HBsAg hepatitis in Italy: a syndrome of Delta hepatitis virus superinfection 151
Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares 151
Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection 150
Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease 149
Detection of hepatitis C virus RNA by reverse-transcriptase and polymerase chain reaction: clinical applications of quantitative analysis 148
Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: a pilot study 147
Bio-mathematical models of viral dynamics to tailor antiviral therapy in chronic viral hepatitis. 147
Does HBeAg minus HBV modify the course of HDV superinfection? 146
Different aspects of HDV and HBV reinfections and liver disease in orthotopic liver transplant (OLT) 146
Totale 17.277
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.828
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.600 0 0 0 0 0 94 192 234 275 211 155 439
2021/20223.601 98 230 46 255 671 543 100 168 200 152 108 1.030
2022/20233.069 505 269 192 250 381 491 34 237 476 20 179 35
2023/20243.461 622 385 488 226 489 646 51 109 74 30 37 304
2024/20258.846 16 389 59 501 448 639 706 505 895 1.308 1.357 2.023
2025/20266.520 631 1.800 1.397 1.019 710 963 0 0 0 0 0 0
Totale 43.318